U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1

WVNews | Business

Mar 12, 2019

NEW YORK--(BUSINESS WIRE)--Mar 11, 2019--Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved TRAZIMERA (trastuzumab-qyy…